Eyeworld

DEC 2019

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1186984

Contents of this Issue

Navigation

Page 82 of 86

improving the cataract patient experience: Minimizing pain and inflammation while reducing the need for topical drops To take this test online and claim credit, go to bit.ly/2PyXJgN or complete the test below and mail or email it in. CME questions (circle the correct answer) 1. Which of the following are risk factors of cystoid macular edema? a. Diabetes b. Glaucoma c. Intraoperative floppy iris syndrome d. All of the above 2. What is the preferred location for dexamethasone suspension? a. In the anterior chamber b. Behind the iris c. In the posterior chamber d. In front of the iris 3. Which of the following is true of dexamethasone intracanalicular inserts? a. It delivers a tapered dose over 30 days. b. It resorbs following treatment. c. It is conjugated with fluorescein. d. All of the above 4. Which of the following is an advantage of mucus-penetrating particle (MPP) technology? a. The smaller particles penetrate the mucus layer more effectively. b. MPP technology may result in higher drug concentrations. c. MPP technology may help reduce patient adherence challenges. d. All of the above 5. Which of the following is true of intracameral phenylephrine/ketorolac? a. It results in a worse patient experience. b. It results in more pain. c. It reduces the need for analgesics. d. It results in more drops after surgery. Copyright 2019 ASCRS Ophthalmic Corporation. All rights reserved. The views expressed in this publication do not necessarily reflect those of the staff and leadership of EyeWorld and ASCRS, and in no way imply endorsement by EyeWorld and ASCRS. To claim credit, email the test and fully completed form by May 31, 2020, to cbraden@ascrs.org, or mail to: EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033, Attn: November 2019 CME Supplement ASCRS Member ID (optional): ––––––––––––––––––––––––––––––––– First/Last Name/Degree: ––––––––––––––––––––––––––––––––– Practice: ––––––––––––––––––––––––––––––––– Address: ––––––––––––––––––––––––––––––––– City, State, Zip, Country: ––––––––––––––––––––––––––––––––– Phone: ––––––––––––––––––––––––––––––––– Email: ––––––––––––––––––––––––––––––––– Please print email address legibly, as CME certificate will be emailed to the address provided. ASCRS

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - DEC 2019